Acorda Therapeutics logo
Acorda Therapeutics ACOR

Quarterly report 2024-Q1
added 05-14-2024

report update icon

Acorda Therapeutics Total Current Liabilities 2011-2026 | ACOR

Annual Total Current Liabilities Acorda Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
228 M 38 M 54 M 137 M 86.4 M 140 M 144 M 148 M 90.6 M 114 M 96.6 M 98.9 M 87.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
228 M 38 M 113 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Assembly Biosciences Assembly Biosciences
ASMB
48.8 M $ 28.46 3.45 % $ 319 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
379 M $ 156.92 -1.23 % $ 7.81 B usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
645 K - -32.59 % $ 7.61 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.37 -4.2 % $ 350 M britainBritain
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
1.8 M $ 10.98 -4.52 % $ 452 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
22.6 M $ 2.09 -0.95 % $ 195 M israelIsrael
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
2.44 M $ 2.28 -0.44 % $ 1.03 M israelIsrael
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Foghorn Therapeutics Foghorn Therapeutics
FHTX
59.7 M $ 5.0 2.25 % $ 315 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.4 -3.68 % $ 1.02 B canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
759 M $ 54.13 -1.64 % $ 10.4 B usaUSA
Curis Curis
CRIS
19 M $ 0.77 1.89 % $ 4.86 M usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
140 M $ 1.52 -5.59 % $ 178 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
22.5 M $ 4.24 -2.97 % $ 704 M canadaCanada
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
16.4 M $ 1.8 -1.1 % $ 120 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
16 M $ 2.94 -3.29 % $ 3.43 M usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
17.6 M $ 0.16 -5.45 % $ 3.15 M irlandaIrlanda
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA